

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 8.87138608 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 8.87138608 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.63233921 |
| 4 | * activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 6.10785049 |
| 5 | * positive regulation of nuclease activity (GO:0032075) | 5.85645588 |
| 6 | COPII vesicle coating (GO:0048208) | 5.63309277 |
| 7 | protein retention in ER lumen (GO:0006621) | 5.42066887 |
| 8 | * regulation of nuclease activity (GO:0032069) | 5.32224464 |
| 9 | * endoplasmic reticulum unfolded protein response (GO:0030968) | 5.23838893 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.18088441 |
| 11 | * cellular response to unfolded protein (GO:0034620) | 5.06439414 |
| 12 | nuclear pore complex assembly (GO:0051292) | 5.06266260 |
| 13 | * ER-nucleus signaling pathway (GO:0006984) | 4.92380826 |
| 14 | * cellular response to topologically incorrect protein (GO:0035967) | 4.72228630 |
| 15 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.63507843 |
| 16 | 4-hydroxyproline metabolic process (GO:0019471) | 4.59737344 |
| 17 | exocrine pancreas development (GO:0031017) | 4.53244859 |
| 18 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.52874038 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.51333513 |
| 20 | endocrine pancreas development (GO:0031018) | 4.46200589 |
| 21 | vesicle coating (GO:0006901) | 4.38495650 |
| 22 | sequestering of metal ion (GO:0051238) | 4.35303802 |
| 23 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 4.28974872 |
| 24 | * response to endoplasmic reticulum stress (GO:0034976) | 4.23508942 |
| 25 | proline biosynthetic process (GO:0006561) | 4.18115519 |
| 26 | type B pancreatic cell development (GO:0003323) | 4.16386271 |
| 27 | DNA unwinding involved in DNA replication (GO:0006268) | 4.14430113 |
| 28 | nuclear pore organization (GO:0006999) | 4.06180363 |
| 29 | glandular epithelial cell development (GO:0002068) | 3.95949662 |
| 30 | intestinal cholesterol absorption (GO:0030299) | 3.95105814 |
| 31 | macroautophagy (GO:0016236) | 3.94834922 |
| 32 | hemidesmosome assembly (GO:0031581) | 3.88997506 |
| 33 | * response to unfolded protein (GO:0006986) | 3.85948814 |
| 34 | mitotic chromosome condensation (GO:0007076) | 3.76479408 |
| 35 | peptide hormone processing (GO:0016486) | 3.67267020 |
| 36 | * response to topologically incorrect protein (GO:0035966) | 3.66852277 |
| 37 | glandular epithelial cell differentiation (GO:0002067) | 3.66814012 |
| 38 | peptidyl-asparagine modification (GO:0018196) | 3.66622395 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 3.65160888 |
| 40 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.64940933 |
| 41 | pore complex assembly (GO:0046931) | 3.63443907 |
| 42 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.60887658 |
| 43 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.60865432 |
| 44 | protein localization to endosome (GO:0036010) | 3.57628405 |
| 45 | regulation of cholesterol homeostasis (GO:2000188) | 3.57088182 |
| 46 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.50677362 |
| 47 | adherens junction assembly (GO:0034333) | 3.40177061 |
| 48 | intestinal absorption (GO:0050892) | 3.38022671 |
| 49 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.36599300 |
| 50 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.34164328 |
| 51 | chromosome condensation (GO:0030261) | 3.33436655 |
| 52 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.32951320 |
| 53 | regulation of RNA export from nucleus (GO:0046831) | 3.30543760 |
| 54 | cell-substrate junction assembly (GO:0007044) | 3.30320658 |
| 55 | protein N-linked glycosylation (GO:0006487) | 3.29901390 |
| 56 | cerebellar Purkinje cell layer development (GO:0021680) | 3.27958070 |
| 57 | focal adhesion assembly (GO:0048041) | 3.26327295 |
| 58 | cell-substrate adherens junction assembly (GO:0007045) | 3.26327295 |
| 59 | ER overload response (GO:0006983) | 3.24787599 |
| 60 | protein complex localization (GO:0031503) | 3.23822563 |
| 61 | Golgi organization (GO:0007030) | 3.23422982 |
| 62 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.17300555 |
| 63 | epithelial cell-cell adhesion (GO:0090136) | 3.16539924 |
| 64 | activation of Rac GTPase activity (GO:0032863) | 3.10215728 |
| 65 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.08756966 |
| 66 | L-phenylalanine catabolic process (GO:0006559) | 3.08756966 |
| 67 | desmosome organization (GO:0002934) | 3.08374672 |
| 68 | peptidyl-proline hydroxylation (GO:0019511) | 3.07502286 |
| 69 | basement membrane organization (GO:0071711) | 3.07265907 |
| 70 | glucose 6-phosphate metabolic process (GO:0051156) | 3.07100658 |
| 71 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.04804288 |
| 72 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.04338707 |
| 73 | intestinal epithelial cell development (GO:0060576) | 3.04221578 |
| 74 | skin morphogenesis (GO:0043589) | 3.01591774 |
| 75 | heterochromatin organization (GO:0070828) | 3.00999192 |
| 76 | cellular response to vitamin D (GO:0071305) | 3.00979460 |
| 77 | L-phenylalanine metabolic process (GO:0006558) | 2.99008964 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.99008964 |
| 79 | apoptotic cell clearance (GO:0043277) | 2.98394187 |
| 80 | protein export from nucleus (GO:0006611) | 2.98114715 |
| 81 | proline metabolic process (GO:0006560) | 2.96977394 |
| 82 | cell adhesion mediated by integrin (GO:0033627) | 2.95602208 |
| 83 | paraxial mesoderm development (GO:0048339) | 2.90553318 |
| 84 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.90366418 |
| 85 | cellular protein complex localization (GO:0034629) | 2.89765958 |
| 86 | protein autoprocessing (GO:0016540) | 2.89339093 |
| 87 | nucleosome disassembly (GO:0006337) | 2.88202678 |
| 88 | protein-DNA complex disassembly (GO:0032986) | 2.88202678 |
| 89 | mannose metabolic process (GO:0006013) | 2.88161300 |
| 90 | hormone catabolic process (GO:0042447) | 2.87417641 |
| 91 | protein localization to microtubule (GO:0035372) | 2.86580231 |
| 92 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.86506782 |
| 93 | maternal placenta development (GO:0001893) | 2.86120504 |
| 94 | establishment of apical/basal cell polarity (GO:0035089) | 2.85711605 |
| 95 | sulfur amino acid catabolic process (GO:0000098) | 2.84713581 |
| 96 | negative regulation of cell size (GO:0045792) | 2.82397885 |
| 97 | regulation of histone H3-K27 methylation (GO:0061085) | 2.82107224 |
| 98 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.81679896 |
| 99 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79256274 |
| 100 | urea cycle (GO:0000050) | 2.78101162 |
| 101 | urea metabolic process (GO:0019627) | 2.78101162 |
| 102 | DNA packaging (GO:0006323) | 2.77441601 |
| 103 | semaphorin-plexin signaling pathway (GO:0071526) | 2.77344618 |
| 104 | positive regulation of insulin secretion (GO:0032024) | 2.76698504 |
| 105 | negative regulation of fibrinolysis (GO:0051918) | 2.75861290 |
| 106 | protein carboxylation (GO:0018214) | 2.75663864 |
| 107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.75663864 |
| 108 | negative regulation of histone methylation (GO:0031061) | 2.74941798 |
| 109 | positive regulation of glycolytic process (GO:0045821) | 2.74558175 |
| 110 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.72847392 |
| 111 | protein hydroxylation (GO:0018126) | 2.72487515 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 2.71363087 |
| 113 | peptidyl-lysine dimethylation (GO:0018027) | 2.68339644 |
| 114 | cellular copper ion homeostasis (GO:0006878) | 2.67472372 |
| 115 | regulation of translational fidelity (GO:0006450) | 2.67336680 |
| 116 | positive regulation of hormone metabolic process (GO:0032352) | 2.66783704 |
| 117 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.65571363 |
| 118 | apoptotic process involved in morphogenesis (GO:0060561) | 2.64879136 |
| 119 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63222317 |
| 120 | membrane protein ectodomain proteolysis (GO:0006509) | 2.61434173 |
| 121 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.61177895 |
| 122 | protein targeting to Golgi (GO:0000042) | 2.60726154 |
| 123 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.60311556 |
| 124 | RNA stabilization (GO:0043489) | 2.59993923 |
| 125 | mRNA stabilization (GO:0048255) | 2.59993923 |
| 126 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.58696681 |
| 127 | tricarboxylic acid metabolic process (GO:0072350) | 2.58328290 |
| 128 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.58090392 |
| 129 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.55545610 |
| 130 | negative regulation of lipid transport (GO:0032369) | 2.55543549 |
| 131 | valine metabolic process (GO:0006573) | 2.54191500 |
| 132 | L-serine metabolic process (GO:0006563) | 2.53173553 |
| 133 | reverse cholesterol transport (GO:0043691) | 2.52802417 |
| 134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.52580243 |
| 135 | gap junction assembly (GO:0016264) | 2.52260705 |
| 136 | establishment of protein localization to Golgi (GO:0072600) | 2.51955621 |
| 137 | pentose-phosphate shunt (GO:0006098) | 2.51791868 |
| 138 | insulin secretion (GO:0030073) | 2.51198798 |
| 139 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.51081940 |
| 140 | convergent extension (GO:0060026) | 2.50900817 |
| 141 | complement activation, alternative pathway (GO:0006957) | 2.50548028 |
| 142 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.49381594 |
| 143 | regulation of translational termination (GO:0006449) | 2.48628150 |
| 144 | histone H3-K36 demethylation (GO:0070544) | 2.47063618 |
| 145 | corticosteroid receptor signaling pathway (GO:0031958) | 2.46683294 |
| 146 | low-density lipoprotein particle clearance (GO:0034383) | 2.46601279 |
| 147 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.46519627 |
| 148 | positive regulation of p38MAPK cascade (GO:1900745) | 2.46450171 |
| 149 | notochord development (GO:0030903) | 2.46393404 |
| 150 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.46195338 |
| 151 | high-density lipoprotein particle remodeling (GO:0034375) | 2.45855324 |
| 152 | endoplasmic reticulum organization (GO:0007029) | 2.45485686 |
| 153 | mitotic sister chromatid cohesion (GO:0007064) | 2.45400501 |
| 154 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44269834 |
| 155 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.43916009 |
| 156 | embryonic process involved in female pregnancy (GO:0060136) | 2.43782117 |
| 157 | mitotic sister chromatid segregation (GO:0000070) | 2.42762032 |
| 158 | protein localization to chromosome, centromeric region (GO:0071459) | 2.42712318 |
| 159 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.42337991 |
| 160 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.42255036 |
| 161 | tetrahydrofolate metabolic process (GO:0046653) | 2.41322164 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.40429955 |
| 163 | response to hexose (GO:0009746) | 2.40057428 |
| 164 | homocysteine metabolic process (GO:0050667) | 2.39074041 |
| 165 | cellular zinc ion homeostasis (GO:0006882) | 2.37428643 |
| 166 | maintenance of protein localization in organelle (GO:0072595) | 2.37312002 |
| 167 | response to glucose (GO:0009749) | 2.37250314 |
| 168 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.37135253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.65858799 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.13337770 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.09062213 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89841968 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.63764146 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.37370165 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 3.21181328 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.07013060 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.87583575 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.81768815 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.58591264 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.54485346 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.48257439 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.40023256 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.27487655 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26515027 |
| 17 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.15073418 |
| 18 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.14040735 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.13860681 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.13114458 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.10854758 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09716510 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.06351253 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85209468 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.79704821 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77498293 |
| 27 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.77297040 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71932621 |
| 29 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.71400662 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67871528 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.67317278 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.64213750 |
| 33 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63629497 |
| 34 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.63238386 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.63169754 |
| 36 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.62862570 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61766238 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.61416509 |
| 39 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.61184015 |
| 40 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.60638874 |
| 41 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.59403560 |
| 42 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.55195181 |
| 43 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.55177318 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.55064391 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54868405 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.54266692 |
| 47 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.53008335 |
| 48 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52992644 |
| 49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52788549 |
| 50 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.50473806 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49084065 |
| 52 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.48800415 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.47996754 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47669346 |
| 55 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44950356 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43299814 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42939037 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.42770342 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42048769 |
| 60 | ATF3_27146783_Chip-Seq_COLON_Human | 1.39400322 |
| 61 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39308002 |
| 62 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38622147 |
| 63 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36866470 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33671573 |
| 65 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.33662946 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33540651 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33286096 |
| 68 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.32926849 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32796256 |
| 70 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31169243 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.31058846 |
| 72 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.28782629 |
| 73 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.28177618 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28049581 |
| 75 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.27815967 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27739308 |
| 77 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.27177673 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25774693 |
| 79 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.25241894 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.24891281 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21912844 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21445700 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21333081 |
| 84 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21268450 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19902439 |
| 86 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19855615 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19823115 |
| 88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19339822 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18498835 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18447412 |
| 91 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.17844883 |
| 92 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17718447 |
| 93 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17671156 |
| 94 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17125328 |
| 95 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16540194 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15737654 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15400527 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14373830 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14280455 |
| 100 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.12760421 |
| 101 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11403537 |
| 102 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.11267390 |
| 103 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10997085 |
| 104 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10717216 |
| 105 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10531102 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07957925 |
| 107 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07723557 |
| 108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07405357 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05248327 |
| 110 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.04289585 |
| 111 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03833539 |
| 112 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03053248 |
| 113 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.02479196 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02275068 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02072553 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01433297 |
| 117 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01213553 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01160221 |
| 119 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00946612 |
| 120 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00518919 |
| 121 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.00375844 |
| 122 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.99828969 |
| 123 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99578626 |
| 124 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99474003 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.99047877 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98899622 |
| 127 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.97579646 |
| 128 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97574919 |
| 129 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97559496 |
| 130 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97243691 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96887215 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96726636 |
| 133 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95268905 |
| 134 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.94667269 |
| 135 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93441910 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93258673 |
| 137 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93258673 |
| 138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.90907758 |
| 139 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89374825 |
| 140 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89331087 |
| 141 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89079942 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86141318 |
| 143 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84988860 |
| 144 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84044311 |
| 145 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.83323512 |
| 146 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83194615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.20124454 |
| 2 | MP0003283_abnormal_digestive_organ | 4.16740823 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.82149288 |
| 4 | MP0005365_abnormal_bile_salt | 3.21292229 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.18040576 |
| 6 | MP0003252_abnormal_bile_duct | 3.09397518 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.00662199 |
| 8 | MP0001944_abnormal_pancreas_morphology | 2.96754742 |
| 9 | MP0002693_abnormal_pancreas_physiology | 2.94966536 |
| 10 | MP0002909_abnormal_adrenal_gland | 2.88806733 |
| 11 | MP0003195_calcinosis | 2.80298786 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.73338033 |
| 13 | MP0005451_abnormal_body_composition | 2.63240192 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.61920938 |
| 15 | MP0004233_abnormal_muscle_weight | 2.57262882 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.55477016 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.47730419 |
| 18 | MP0010234_abnormal_vibrissa_follicle | 2.42859949 |
| 19 | MP0005360_urolithiasis | 2.34682898 |
| 20 | MP0005076_abnormal_cell_differentiation | 2.30018203 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.25552937 |
| 22 | MP0004043_abnormal_pH_regulation | 2.17769754 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.17674088 |
| 24 | MP0003868_abnormal_feces_composition | 2.16034327 |
| 25 | MP0004858_abnormal_nervous_system | 2.07216912 |
| 26 | MP0005623_abnormal_meninges_morphology | 2.05492758 |
| 27 | MP0001730_embryonic_growth_arrest | 2.05224709 |
| 28 | MP0000678_abnormal_parathyroid_gland | 2.04875262 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.99954800 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.94081578 |
| 31 | MP0005083_abnormal_biliary_tract | 1.92002021 |
| 32 | MP0010352_gastrointestinal_tract_polyps | 1.88280442 |
| 33 | MP0003941_abnormal_skin_development | 1.87966215 |
| 34 | MP0000566_synostosis | 1.82124841 |
| 35 | MP0002078_abnormal_glucose_homeostasis | 1.80835487 |
| 36 | MP0005409_darkened_coat_color | 1.79156716 |
| 37 | MP0002928_abnormal_bile_duct | 1.74897882 |
| 38 | MP0002796_impaired_skin_barrier | 1.73320581 |
| 39 | MP0009840_abnormal_foam_cell | 1.70308853 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.69755518 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.68555016 |
| 42 | MP0002089_abnormal_postnatal_growth/wei | 1.66219631 |
| 43 | MP0000579_abnormal_nail_morphology | 1.64105544 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.60598487 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.59116684 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.56798652 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.56792779 |
| 48 | MP0001672_abnormal_embryogenesis/_devel | 1.53780873 |
| 49 | MP0005380_embryogenesis_phenotype | 1.53780873 |
| 50 | MP0006054_spinal_hemorrhage | 1.52045708 |
| 51 | MP0003045_fibrosis | 1.51958881 |
| 52 | MP0010329_abnormal_lipoprotein_level | 1.50785454 |
| 53 | MP0003091_abnormal_cell_migration | 1.50029816 |
| 54 | MP0008932_abnormal_embryonic_tissue | 1.49442991 |
| 55 | MP0003984_embryonic_growth_retardation | 1.48258292 |
| 56 | MP0003183_abnormal_peptide_metabolism | 1.47656471 |
| 57 | MP0009643_abnormal_urine_homeostasis | 1.43895598 |
| 58 | MP0003077_abnormal_cell_cycle | 1.41960809 |
| 59 | MP0000609_abnormal_liver_physiology | 1.40804724 |
| 60 | MP0002060_abnormal_skin_morphology | 1.40400851 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 1.40195736 |
| 62 | MP0000350_abnormal_cell_proliferation | 1.39956032 |
| 63 | MP0005501_abnormal_skin_physiology | 1.39911257 |
| 64 | * MP0002080_prenatal_lethality | 1.39415891 |
| 65 | MP0003303_peritoneal_inflammation | 1.37548268 |
| 66 | MP0004782_abnormal_surfactant_physiolog | 1.37381795 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.35054585 |
| 68 | MP0001915_intracranial_hemorrhage | 1.29284732 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.28635947 |
| 70 | MP0000613_abnormal_salivary_gland | 1.26830501 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.26820310 |
| 72 | MP0009672_abnormal_birth_weight | 1.25837186 |
| 73 | MP0003172_abnormal_lysosome_physiology | 1.25109429 |
| 74 | MP0002085_abnormal_embryonic_tissue | 1.24988713 |
| 75 | MP0001765_abnormal_ion_homeostasis | 1.21383825 |
| 76 | MP0005187_abnormal_penis_morphology | 1.20533915 |
| 77 | MP0003329_amyloid_beta_deposits | 1.20273207 |
| 78 | MP0001697_abnormal_embryo_size | 1.19633392 |
| 79 | MP0010094_abnormal_chromosome_stability | 1.19473813 |
| 80 | MP0000467_abnormal_esophagus_morphology | 1.16515328 |
| 81 | MP0003385_abnormal_body_wall | 1.13498077 |
| 82 | MP0002254_reproductive_system_inflammat | 1.13089408 |
| 83 | MP0002138_abnormal_hepatobiliary_system | 1.12419985 |
| 84 | MP0005621_abnormal_cell_physiology | 1.12049967 |
| 85 | MP0005058_abnormal_lysosome_morphology | 1.10558240 |
| 86 | MP0001216_abnormal_epidermal_layer | 1.09037341 |
| 87 | MP0000762_abnormal_tongue_morphology | 1.08145696 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.07624473 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05960233 |
| 90 | MP0003119_abnormal_digestive_system | 1.05305169 |
| 91 | MP0002697_abnormal_eye_size | 1.03945635 |
| 92 | MP0003959_abnormal_lean_body | 1.03402197 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 1.03145085 |
| 94 | MP0005379_endocrine/exocrine_gland_phen | 1.02894836 |
| 95 | MP0005375_adipose_tissue_phenotype | 1.01119587 |
| 96 | MP0003315_abnormal_perineum_morphology | 1.00424874 |
| 97 | MP0000462_abnormal_digestive_system | 1.00353589 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 1.00243078 |
| 99 | MP0005332_abnormal_amino_acid | 0.98547261 |
| 100 | MP0001756_abnormal_urination | 0.98105584 |
| 101 | MP0000627_abnormal_mammary_gland | 0.96852025 |
| 102 | MP0003953_abnormal_hormone_level | 0.96152938 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.96025456 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.95399386 |
| 105 | MP0002098_abnormal_vibrissa_morphology | 0.95068323 |
| 106 | MP0010307_abnormal_tumor_latency | 0.94859922 |
| 107 | MP0003942_abnormal_urinary_system | 0.93993625 |
| 108 | MP0009703_decreased_birth_body | 0.93431120 |
| 109 | MP0004272_abnormal_basement_membrane | 0.93193326 |
| 110 | MP0000534_abnormal_ureter_morphology | 0.93174221 |
| 111 | MP0000733_abnormal_muscle_development | 0.92869063 |
| 112 | MP0000858_altered_metastatic_potential | 0.92837196 |
| 113 | MP0008260_abnormal_autophagy | 0.92554156 |
| 114 | MP0003890_abnormal_embryonic-extraembry | 0.91691281 |
| 115 | MP0001849_ear_inflammation | 0.91007037 |
| 116 | MP0001346_abnormal_lacrimal_gland | 0.90035487 |
| 117 | MP0000377_abnormal_hair_follicle | 0.88524871 |
| 118 | MP0008057_abnormal_DNA_replication | 0.88015830 |
| 119 | MP0000537_abnormal_urethra_morphology | 0.87725864 |
| 120 | MP0000598_abnormal_liver_morphology | 0.86515970 |
| 121 | MP0005384_cellular_phenotype | 0.85933190 |
| 122 | MP0002168_other_aberrant_phenotype | 0.85588673 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.85025753 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.84470822 |
| 125 | MP0005310_abnormal_salivary_gland | 0.84301789 |
| 126 | MP0000428_abnormal_craniofacial_morphol | 0.83919164 |
| 127 | MP0005666_abnormal_adipose_tissue | 0.80266616 |
| 128 | MP0005408_hypopigmentation | 0.80097846 |
| 129 | MP0004808_abnormal_hematopoietic_stem | 0.78822571 |
| 130 | MP0004197_abnormal_fetal_growth/weight/ | 0.78748150 |
| 131 | MP0000432_abnormal_head_morphology | 0.78111441 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.78050982 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.76907016 |
| 134 | MP0000639_abnormal_adrenal_gland | 0.76593025 |
| 135 | MP0009931_abnormal_skin_appearance | 0.76396403 |
| 136 | MP0003191_abnormal_cellular_cholesterol | 0.76351899 |
| 137 | MP0001661_extended_life_span | 0.76206523 |
| 138 | MP0001881_abnormal_mammary_gland | 0.76108819 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.73769687 |
| 140 | MP0003866_abnormal_defecation | 0.72909630 |
| 141 | MP0002092_abnormal_eye_morphology | 0.72032126 |
| 142 | MP0005023_abnormal_wound_healing | 0.70162433 |
| 143 | MP0008438_abnormal_cutaneous_collagen | 0.70034178 |
| 144 | MP0005334_abnormal_fat_pad | 0.69891387 |
| 145 | MP0010678_abnormal_skin_adnexa | 0.69456986 |
| 146 | MP0000371_diluted_coat_color | 0.69300627 |
| 147 | MP0002166_altered_tumor_susceptibility | 0.69280753 |
| 148 | MP0003935_abnormal_craniofacial_develop | 0.69152663 |
| 149 | MP0002249_abnormal_larynx_morphology | 0.69023131 |
| 150 | MP0010368_abnormal_lymphatic_system | 0.68942768 |
| 151 | MP0009642_abnormal_blood_homeostasis | 0.66956634 |
| 152 | MP0005636_abnormal_mineral_homeostasis | 0.65247781 |
| 153 | MP0001270_distended_abdomen | 0.64522377 |
| 154 | MP0002086_abnormal_extraembryonic_tissu | 0.64122711 |
| 155 | MP0005670_abnormal_white_adipose | 0.63362803 |
| 156 | MP0005448_abnormal_energy_balance | 0.63316779 |
| 157 | MP0009053_abnormal_anal_canal | 0.60002060 |
| 158 | MP0003115_abnormal_respiratory_system | 0.55346122 |
| 159 | MP0002970_abnormal_white_adipose | 0.55281281 |
| 160 | MP0001299_abnormal_eye_distance/ | 0.55171096 |
| 161 | MP0003123_paternal_imprinting | 0.54260757 |
| 162 | MP0005647_abnormal_sex_gland | 0.53196732 |
| 163 | MP0003122_maternal_imprinting | 0.52576066 |
| 164 | MP0002084_abnormal_developmental_patter | 0.50949284 |
| 165 | MP0003795_abnormal_bone_structure | 0.50875967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.20935257 |
| 2 | Hypoglycemic seizures (HP:0002173) | 5.47415741 |
| 3 | Hypoglycemic coma (HP:0001325) | 5.11375669 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.39822628 |
| 5 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.31869834 |
| 6 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.31869834 |
| 7 | Symptomatic seizures (HP:0011145) | 4.31744208 |
| 8 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.97153610 |
| 9 | Late onset (HP:0003584) | 3.96010537 |
| 10 | Hyperglycemia (HP:0003074) | 3.95108923 |
| 11 | Abnormality of the intrinsic pathway (HP:0010989) | 3.76450978 |
| 12 | Premature rupture of membranes (HP:0001788) | 3.75029532 |
| 13 | Ketoacidosis (HP:0001993) | 3.59596222 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.58985043 |
| 15 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.58880465 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.48030506 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 3.42451215 |
| 18 | Protrusio acetabuli (HP:0003179) | 3.30808267 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.30230706 |
| 20 | Mucopolysacchariduria (HP:0008155) | 3.30230706 |
| 21 | Deep venous thrombosis (HP:0002625) | 3.01998154 |
| 22 | Flat acetabular roof (HP:0003180) | 2.99254223 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.96301273 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.96301273 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.96301273 |
| 26 | Large for gestational age (HP:0001520) | 2.93759375 |
| 27 | Insulin resistance (HP:0000855) | 2.92196885 |
| 28 | Ketosis (HP:0001946) | 2.85564433 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.82873794 |
| 30 | Cerebral aneurysm (HP:0004944) | 2.75611885 |
| 31 | Insomnia (HP:0100785) | 2.73502454 |
| 32 | Agitation (HP:0000713) | 2.72929891 |
| 33 | Xanthomatosis (HP:0000991) | 2.67815073 |
| 34 | Asymmetry of the thorax (HP:0001555) | 2.65941755 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.65156891 |
| 36 | Back pain (HP:0003418) | 2.61302555 |
| 37 | Broad face (HP:0000283) | 2.60601857 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 2.60145049 |
| 39 | Unilateral renal agenesis (HP:0000122) | 2.57788130 |
| 40 | Abnormal pancreas size (HP:0012094) | 2.53920099 |
| 41 | Skin nodule (HP:0200036) | 2.48568549 |
| 42 | Ulnar bowing (HP:0003031) | 2.48288600 |
| 43 | Hand muscle atrophy (HP:0009130) | 2.47761219 |
| 44 | Shallow orbits (HP:0000586) | 2.47194838 |
| 45 | Atrophic scars (HP:0001075) | 2.45417717 |
| 46 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.42748353 |
| 47 | Aneurysm (HP:0002617) | 2.39743466 |
| 48 | Abnormality of oral frenula (HP:0000190) | 2.39671687 |
| 49 | Retinal atrophy (HP:0001105) | 2.39640518 |
| 50 | Macroorchidism (HP:0000053) | 2.36826426 |
| 51 | Hypercortisolism (HP:0001578) | 2.36402973 |
| 52 | Abdominal distention (HP:0003270) | 2.35867054 |
| 53 | Short nail (HP:0001799) | 2.33965410 |
| 54 | Complement deficiency (HP:0004431) | 2.29290704 |
| 55 | Long palpebral fissure (HP:0000637) | 2.27822248 |
| 56 | Advanced eruption of teeth (HP:0006288) | 2.27619722 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.27210518 |
| 58 | Insidious onset (HP:0003587) | 2.26555229 |
| 59 | Termporal pattern (HP:0011008) | 2.26555229 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.26293275 |
| 61 | Thoracolumbar scoliosis (HP:0002944) | 2.21389534 |
| 62 | Missing ribs (HP:0000921) | 2.20506975 |
| 63 | Congenital glaucoma (HP:0001087) | 2.20446607 |
| 64 | Prominent metopic ridge (HP:0005487) | 2.19676373 |
| 65 | Disproportionate tall stature (HP:0001519) | 2.18401281 |
| 66 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.17937566 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.15707962 |
| 68 | Exocrine pancreatic insufficiency (HP:0001738) | 2.15366436 |
| 69 | Abnormality of dentin (HP:0010299) | 2.14402633 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.13876017 |
| 71 | Cholecystitis (HP:0001082) | 2.13876017 |
| 72 | Deviation of the thumb (HP:0009603) | 2.11883104 |
| 73 | Arterial tortuosity (HP:0005116) | 2.10695044 |
| 74 | Abnormality of carpal bone ossification (HP:0006257) | 2.09385096 |
| 75 | Upper limb amyotrophy (HP:0009129) | 2.08091537 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 2.08091537 |
| 77 | Selective tooth agenesis (HP:0001592) | 2.07196004 |
| 78 | Turricephaly (HP:0000262) | 2.04812133 |
| 79 | Fragile skin (HP:0001030) | 2.03800804 |
| 80 | Restlessness (HP:0000711) | 2.03412339 |
| 81 | Increased nuchal translucency (HP:0010880) | 2.03395146 |
| 82 | Renal duplication (HP:0000075) | 2.02651082 |
| 83 | Fat malabsorption (HP:0002630) | 2.02143282 |
| 84 | Abnormal ossification of hand bones (HP:0005921) | 2.01902101 |
| 85 | Natal tooth (HP:0000695) | 2.01709563 |
| 86 | Patellar dislocation (HP:0002999) | 2.00890497 |
| 87 | Severe short stature (HP:0003510) | 2.00346172 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 1.98200260 |
| 89 | Overriding aorta (HP:0002623) | 1.96174699 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 1.95947135 |
| 91 | Blue sclerae (HP:0000592) | 1.95943820 |
| 92 | Epidermoid cyst (HP:0200040) | 1.93973339 |
| 93 | Abnormality of the metopic suture (HP:0005556) | 1.91716965 |
| 94 | Right ventricular cardiomyopathy (HP:0011663) | 1.91443516 |
| 95 | Osteolytic defects of the hand bones (HP:0009699) | 1.90780235 |
| 96 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90780235 |
| 97 | Trismus (HP:0000211) | 1.89714535 |
| 98 | Hyperparathyroidism (HP:0000843) | 1.89701572 |
| 99 | Cortical dysplasia (HP:0002539) | 1.88729193 |
| 100 | Pterygium (HP:0001059) | 1.88495338 |
| 101 | Dysmetric saccades (HP:0000641) | 1.87852904 |
| 102 | Overlapping toe (HP:0001845) | 1.87611398 |
| 103 | Renovascular hypertension (HP:0100817) | 1.87199896 |
| 104 | Subacute progressive viral hepatitis (HP:0006572) | 1.87134658 |
| 105 | Bladder diverticulum (HP:0000015) | 1.86520301 |
| 106 | Abnormality of the acetabulum (HP:0003170) | 1.86367717 |
| 107 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86270257 |
| 108 | Resting tremor (HP:0002322) | 1.85978368 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.85403488 |
| 110 | Protuberant abdomen (HP:0001538) | 1.84773312 |
| 111 | Abnormality of complement system (HP:0005339) | 1.84493762 |
| 112 | Bronchomalacia (HP:0002780) | 1.83613963 |
| 113 | Long toe (HP:0010511) | 1.83251850 |
| 114 | Reticulocytosis (HP:0001923) | 1.83030036 |
| 115 | Global brain atrophy (HP:0002283) | 1.81440024 |
| 116 | Progressive hearing impairment (HP:0001730) | 1.81432367 |
| 117 | Hyperacusis (HP:0010780) | 1.81398777 |
| 118 | Arnold-Chiari malformation (HP:0002308) | 1.81397762 |
| 119 | Wormian bones (HP:0002645) | 1.81176877 |
| 120 | Myocardial infarction (HP:0001658) | 1.80466447 |
| 121 | Elfin facies (HP:0004428) | 1.79946574 |
| 122 | Increased CSF protein (HP:0002922) | 1.79823567 |
| 123 | Striae distensae (HP:0001065) | 1.79776943 |
| 124 | Prolonged partial thromboplastin time (HP:0003645) | 1.79774535 |
| 125 | Thin bony cortex (HP:0002753) | 1.79407379 |
| 126 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79298984 |
| 127 | Enlarged penis (HP:0000040) | 1.79201928 |
| 128 | Elevated alkaline phosphatase (HP:0003155) | 1.78913548 |
| 129 | Vascular tortuosity (HP:0004948) | 1.77139883 |
| 130 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76782861 |
| 131 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75842213 |
| 132 | Flattened epiphyses (HP:0003071) | 1.75799473 |
| 133 | Hypokalemia (HP:0002900) | 1.75360352 |
| 134 | Abnormality of the salivary glands (HP:0010286) | 1.75342040 |
| 135 | Papilledema (HP:0001085) | 1.75155383 |
| 136 | Spinal rigidity (HP:0003306) | 1.73318568 |
| 137 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.72916475 |
| 138 | Biconcave vertebral bodies (HP:0004586) | 1.72742226 |
| 139 | Proximal placement of thumb (HP:0009623) | 1.72730243 |
| 140 | Vertebral arch anomaly (HP:0008438) | 1.71451798 |
| 141 | Abnormal foot bone ossification (HP:0010675) | 1.70386633 |
| 142 | Ankle contracture (HP:0006466) | 1.69514392 |
| 143 | Increased connective tissue (HP:0009025) | 1.69000625 |
| 144 | Abnormality of purine metabolism (HP:0004352) | 1.68983842 |
| 145 | Midface retrusion (HP:0011800) | 1.68860415 |
| 146 | Relative macrocephaly (HP:0004482) | 1.68091974 |
| 147 | Premature skin wrinkling (HP:0100678) | 1.67952343 |
| 148 | Long eyelashes (HP:0000527) | 1.67802986 |
| 149 | Menorrhagia (HP:0000132) | 1.66821396 |
| 150 | Hypophosphatemia (HP:0002148) | 1.65697672 |
| 151 | Cervical subluxation (HP:0003308) | 1.64673635 |
| 152 | Hammertoe (HP:0001765) | 1.64177324 |
| 153 | Limb hypertonia (HP:0002509) | 1.63322902 |
| 154 | Abnormal tarsal ossification (HP:0008369) | 1.62786075 |
| 155 | Bowel diverticulosis (HP:0005222) | 1.62637337 |
| 156 | Neonatal death (HP:0003811) | 1.62144860 |
| 157 | Hepatocellular carcinoma (HP:0001402) | 1.62144620 |
| 158 | Pseudobulbar signs (HP:0002200) | 1.61143951 |
| 159 | Upper limb muscle weakness (HP:0003484) | 1.60794138 |
| 160 | Abnormal biliary tract morphology (HP:0012440) | 1.59091304 |
| 161 | Decreased circulating renin level (HP:0003351) | 1.59065445 |
| 162 | Micronodular cirrhosis (HP:0001413) | 1.58994314 |
| 163 | Abnormality of the thoracic spine (HP:0100711) | 1.58562161 |
| 164 | Spastic diplegia (HP:0001264) | 1.58343274 |
| 165 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57137501 |
| 166 | Urethral obstruction (HP:0000796) | 1.56795456 |
| 167 | Gout (HP:0001997) | 1.56503596 |
| 168 | Mitral valve prolapse (HP:0001634) | 1.56287987 |
| 169 | Lymphangioma (HP:0100764) | 1.56278854 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.55975112 |
| 171 | Small epiphyses (HP:0010585) | 1.55941860 |
| 172 | Breech presentation (HP:0001623) | 1.55581850 |
| 173 | Generalized aminoaciduria (HP:0002909) | 1.54243232 |
| 174 | Abnormality of the gastric mucosa (HP:0004295) | 1.54161671 |
| 175 | Hypobetalipoproteinemia (HP:0003563) | 1.54070954 |
| 176 | Septate vagina (HP:0001153) | 1.53902456 |
| 177 | Hemorrhage of the eye (HP:0011885) | 1.53661327 |
| 178 | Pili torti (HP:0003777) | 1.53632581 |
| 179 | Heterotopia (HP:0002282) | 1.53602189 |
| 180 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.53122532 |
| 181 | Microglossia (HP:0000171) | 1.52615310 |
| 182 | Abnormal delivery (HP:0001787) | 1.52290457 |
| 183 | Spinal cord compression (HP:0002176) | 1.52032623 |
| 184 | Coxa vara (HP:0002812) | 1.51810067 |
| 185 | Rectal prolapse (HP:0002035) | 1.50896877 |
| 186 | Death in childhood (HP:0003819) | 1.50781299 |
| 187 | Lower limb hyperreflexia (HP:0002395) | 1.49111509 |
| 188 | Ankyloglossia (HP:0010296) | 1.48548186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.74194830 |
| 2 | TAOK3 | 4.22814274 |
| 3 | INSRR | 4.04166467 |
| 4 | SMG1 | 3.80692339 |
| 5 | PASK | 3.77591556 |
| 6 | TRIB3 | 3.73637478 |
| 7 | PKN2 | 2.64192394 |
| 8 | SCYL2 | 2.49015783 |
| 9 | FRK | 2.41690194 |
| 10 | LATS1 | 2.39617251 |
| 11 | EEF2K | 2.35534057 |
| 12 | SIK1 | 2.34145233 |
| 13 | PTK6 | 2.26913700 |
| 14 | LATS2 | 2.26826961 |
| 15 | PDGFRA | 2.22908639 |
| 16 | CDK12 | 2.14813853 |
| 17 | PRKD3 | 2.10346027 |
| 18 | HIPK2 | 1.96982680 |
| 19 | MAP3K10 | 1.95771281 |
| 20 | MAP3K2 | 1.93563184 |
| 21 | FLT3 | 1.81506427 |
| 22 | PRPF4B | 1.81446937 |
| 23 | TSSK6 | 1.64444346 |
| 24 | LMTK2 | 1.53992315 |
| 25 | TTK | 1.47211658 |
| 26 | MAP3K9 | 1.45145168 |
| 27 | MAPK15 | 1.41890816 |
| 28 | MAP3K1 | 1.40390172 |
| 29 | FGFR4 | 1.35972363 |
| 30 | RIPK1 | 1.33847401 |
| 31 | PTK2 | 1.30318858 |
| 32 | BCKDK | 1.28325788 |
| 33 | MTOR | 1.26848343 |
| 34 | EPHA2 | 1.22029951 |
| 35 | ICK | 1.21802744 |
| 36 | PRKCH | 1.13526154 |
| 37 | SRPK1 | 1.13462002 |
| 38 | CDK7 | 1.12486499 |
| 39 | ALK | 1.09377528 |
| 40 | ARAF | 1.08757634 |
| 41 | AKT3 | 1.07526060 |
| 42 | EIF2AK1 | 1.02932037 |
| 43 | MET | 1.01274208 |
| 44 | JAK2 | 0.99341657 |
| 45 | RET | 0.96754946 |
| 46 | NME2 | 0.93325265 |
| 47 | FER | 0.92745054 |
| 48 | PRKD2 | 0.91560795 |
| 49 | EPHA3 | 0.90172444 |
| 50 | DYRK1B | 0.89576370 |
| 51 | NTRK1 | 0.86821883 |
| 52 | CDC42BPA | 0.86795283 |
| 53 | PAK2 | 0.86749005 |
| 54 | CAMK1G | 0.83617233 |
| 55 | BMX | 0.83067588 |
| 56 | JAK1 | 0.81204132 |
| 57 | TTN | 0.79330933 |
| 58 | EPHB1 | 0.79037748 |
| 59 | CAMK1D | 0.78225767 |
| 60 | FGFR3 | 0.77619613 |
| 61 | BRAF | 0.76874305 |
| 62 | TYRO3 | 0.74874505 |
| 63 | IRAK3 | 0.74134624 |
| 64 | PDGFRB | 0.73868757 |
| 65 | CDC7 | 0.73513106 |
| 66 | LRRK2 | 0.70169588 |
| 67 | CDK6 | 0.68724013 |
| 68 | MAP2K2 | 0.68239067 |
| 69 | CLK1 | 0.66603876 |
| 70 | UHMK1 | 0.65235495 |
| 71 | MAPK11 | 0.65010110 |
| 72 | CHEK1 | 0.64398811 |
| 73 | WNK4 | 0.64383011 |
| 74 | PNCK | 0.63108861 |
| 75 | MAP3K13 | 0.60389335 |
| 76 | TESK1 | 0.59609449 |
| 77 | STK3 | 0.59322463 |
| 78 | BRD4 | 0.59175791 |
| 79 | PRKAA1 | 0.59104000 |
| 80 | PBK | 0.57435607 |
| 81 | TESK2 | 0.57166561 |
| 82 | PRKG2 | 0.56993204 |
| 83 | CDK8 | 0.56968523 |
| 84 | EIF2AK3 | 0.56778647 |
| 85 | CDK9 | 0.56621135 |
| 86 | VRK2 | 0.56395516 |
| 87 | PAK4 | 0.55846351 |
| 88 | GSK3A | 0.54086996 |
| 89 | RPS6KA2 | 0.52564267 |
| 90 | KSR2 | 0.52538640 |
| 91 | CAMKK1 | 0.51865102 |
| 92 | PDPK1 | 0.49615272 |
| 93 | JAK3 | 0.47854792 |
| 94 | MAP3K3 | 0.47518781 |
| 95 | PRKD1 | 0.46662910 |
| 96 | TAOK2 | 0.46604268 |
| 97 | CSK | 0.46366094 |
| 98 | TAF1 | 0.45668600 |
| 99 | CHEK2 | 0.43717583 |
| 100 | STK38 | 0.43643516 |
| 101 | PAK3 | 0.43466912 |
| 102 | BUB1 | 0.43270772 |
| 103 | BRSK2 | 0.42754131 |
| 104 | CDK1 | 0.42304571 |
| 105 | SGK3 | 0.42103145 |
| 106 | PIK3CG | 0.41881445 |
| 107 | MAP3K8 | 0.41679479 |
| 108 | CDK2 | 0.40813946 |
| 109 | RPS6KB2 | 0.40379767 |
| 110 | AURKB | 0.39964842 |
| 111 | ZAP70 | 0.39689470 |
| 112 | ROCK2 | 0.39335804 |
| 113 | BRSK1 | 0.39174370 |
| 114 | AURKA | 0.39152771 |
| 115 | DDR2 | 0.39019876 |
| 116 | AKT2 | 0.38481776 |
| 117 | MAP3K7 | 0.37811271 |
| 118 | MST1R | 0.37375332 |
| 119 | NEK1 | 0.36817152 |
| 120 | CHUK | 0.34678468 |
| 121 | MAPK10 | 0.34516790 |
| 122 | CDK11A | 0.34176544 |
| 123 | CDK15 | 0.34010093 |
| 124 | WNK1 | 0.33663240 |
| 125 | BTK | 0.33006117 |
| 126 | MAPK14 | 0.32065315 |
| 127 | TAOK1 | 0.32040190 |
| 128 | PRKCI | 0.31158583 |
| 129 | RPS6KB1 | 0.30500875 |
| 130 | PRKDC | 0.29664953 |
| 131 | EGFR | 0.29577855 |
| 132 | MAPKAPK3 | 0.29257846 |
| 133 | STK10 | 0.28408542 |
| 134 | MARK2 | 0.27125179 |
| 135 | FGFR1 | 0.27101925 |
| 136 | ITK | 0.27059964 |
| 137 | ERBB4 | 0.26591164 |
| 138 | FGFR2 | 0.26371150 |
| 139 | CDK4 | 0.25983905 |
| 140 | NEK2 | 0.25615763 |
| 141 | CAMKK2 | 0.25456084 |
| 142 | TYK2 | 0.24869649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.70858973 |
| 2 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.48365708 |
| 3 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.69001350 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.63578030 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.27362151 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25730076 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.09846081 |
| 8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.82084204 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81703338 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79387474 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 1.71849288 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63361859 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.62081950 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.59011915 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.55335785 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.53753892 |
| 17 | Lysine degradation_Homo sapiens_hsa00310 | 1.53248202 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.52546713 |
| 19 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.48265020 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46382445 |
| 21 | Insulin resistance_Homo sapiens_hsa04931 | 1.42980718 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42719061 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.42372293 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42102415 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.41025019 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.39699629 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.37998709 |
| 28 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.37218776 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34504044 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28593657 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27641477 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27638266 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27564290 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24653710 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21870574 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21645013 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.20238820 |
| 38 | Cell cycle_Homo sapiens_hsa04110 | 1.14206265 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13053752 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.09087137 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08829808 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.08642223 |
| 43 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.07932580 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07328974 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07084054 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06983489 |
| 47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05966510 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.04976986 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.01706941 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00831726 |
| 51 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99977789 |
| 52 | RNA transport_Homo sapiens_hsa03013 | 0.99268826 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.98811267 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98333217 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94369158 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92022477 |
| 57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91720920 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.89774202 |
| 59 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89108478 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.88895035 |
| 61 | Lysosome_Homo sapiens_hsa04142 | 0.88161955 |
| 62 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.87159920 |
| 63 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.83013828 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.82766645 |
| 65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78787958 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78241823 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77882511 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76459095 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76101998 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75645534 |
| 71 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.75560495 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 0.74792372 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74143893 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73228469 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72883458 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71569464 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71051669 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70951009 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68706977 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68452324 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68434502 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65704153 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.64720996 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63945731 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63024618 |
| 86 | Adherens junction_Homo sapiens_hsa04520 | 0.62772023 |
| 87 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62515341 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.59993589 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.59706749 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.57991327 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.57768189 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57322275 |
| 93 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57099566 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56883073 |
| 95 | Focal adhesion_Homo sapiens_hsa04510 | 0.56485776 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56397361 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55956383 |
| 98 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55637720 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55220862 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54741001 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53349672 |
| 102 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52332355 |
| 103 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52134801 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52020555 |
| 105 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51646893 |
| 106 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.51352182 |
| 107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51311873 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51102557 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.50664801 |
| 110 | Melanogenesis_Homo sapiens_hsa04916 | 0.50488377 |
| 111 | Base excision repair_Homo sapiens_hsa03410 | 0.50153236 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.49953028 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48770463 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.48649289 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.48433506 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48343091 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48074004 |
| 118 | Cocaine addiction_Homo sapiens_hsa05030 | 0.48066693 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47275321 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46275636 |
| 121 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.45673052 |
| 122 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.45317666 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44905306 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43685104 |
| 125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43415213 |
| 126 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43166633 |
| 127 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.42723244 |
| 128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41872748 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41268642 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40747947 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39497105 |
| 132 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.38732612 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38664535 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37794958 |
| 135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.36439337 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33823077 |
| 137 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.32687794 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31795473 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31345058 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.31047216 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30890130 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30302380 |
| 143 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27240600 |
| 144 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27157396 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25566719 |
| 146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25208837 |

